Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ketamine for ESP block in pediatric thoracotomy
NCT05552391Phase 4
Key facts
- Status
- Completed
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Countries
- 1
- Sponsor
- Kasr Al Ainy Hospital
- Modality
- Small Molecules
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine in postoperative pain, sponsored by Kasr Al Ainy Hospital. Started Sep 2022; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Pediatric patients aged 3-36 months, weighing >5 kg, undergoing thoracotomy, excluding those with coagulopathy, local infection, or hypersensitivity to the study drugs.
04
Registry description
A double-blind randomized control study to compare the efficacy of dexmedetomidine versus ketamine as an adjuvant in combination with bupivacaine ultrasound-guided ESP block in patients scheduled for cardiothoracic surgeries with thoracotomy incision.
Beyond the preview
Go deeper on NCT05552391.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05552391.